By contrast, Alzheimer’s disease neuropathologic change (ADNC) is characterized by the presence of β-amyloid (Aβ) deposits in the form of neuritic plaques (NP) and tau-immunoreactive NFT without an extensive glial pathology [7, 8]. The gene discussed is MAPT; the disease is Alzheimer disease.